BACKGROUND: Factors such as age, sex and disease state alter a patient's susceptibility to adverse drug reactions (ADRs). Ethnicity may also alter the risk of an ADR. OBJECTIVE: To review the evidence for ethnic differences in susceptibility to adverse reactions to drugs used to treat psychoses and depression. DATA SOURCES: We searched MEDLINE (from 1951), EMBASE (from 1974), and PsycINFO (from 1950) to March 2006. STUDY SELECTION: Studies were included if there was a mention of ethnicity, ethnic or racial groups and a description of a procedure to investigate ADRs specifically or a description of ADRs that were a result of drugs in therapeutic use. Studies selected by any two reviewers were retained if they referred to drugs used in the treatment of psychoses and related disorders or antidepressant drugs. Of 124 studies describing ADRs to antipsychotics or antidepressants, 51 reported data from different ethnic groups. DATA EXTRACTION: Data were extracted independently from those studies selected for inclusion by two reviewers, using a standard data extraction form. Studies were assessed for bias in order to determine the quality of the study. DATA SYNTHESIS: In a pooled analysis of patients treated with antipsychotics, the relative risk (RR) of tardive dyskinesia in Black compared with White patients was 1.03 (95% CI 0.85, 1.24); the RR of extrapyramidal symptoms in East Asian compared with non-East Asian patients was 1.38 (95% CI 1.11, 1.72); the RR of hyperglycaemia in Black compared with non-Black patients was 1.55 (95% CI 0.95, 2.53); and the RR of diabetes mellitus in non-White compared with White patients was 1.35 (95% CI 0.95, 1.92). It was impossible to perform pooled analysis of data from studies investigating antidepressants due to insufficient data. CONCLUSIONS: We found limited evidence of ethnic differences in the risk of ADRs. The clinical implications of these results remain unclear because of confounding factors. Further progress will require improved recruitment of patients from different ethnic groups and an established consensus on how to define ethnicity.
BACKGROUND: Factors such as age, sex and disease state alter a patient's susceptibility to adverse drug reactions (ADRs). Ethnicity may also alter the risk of an ADR. OBJECTIVE: To review the evidence for ethnic differences in susceptibility to adverse reactions to drugs used to treat psychoses and depression. DATA SOURCES: We searched MEDLINE (from 1951), EMBASE (from 1974), and PsycINFO (from 1950) to March 2006. STUDY SELECTION: Studies were included if there was a mention of ethnicity, ethnic or racial groups and a description of a procedure to investigate ADRs specifically or a description of ADRs that were a result of drugs in therapeutic use. Studies selected by any two reviewers were retained if they referred to drugs used in the treatment of psychoses and related disorders or antidepressant drugs. Of 124 studies describing ADRs to antipsychotics or antidepressants, 51 reported data from different ethnic groups. DATA EXTRACTION: Data were extracted independently from those studies selected for inclusion by two reviewers, using a standard data extraction form. Studies were assessed for bias in order to determine the quality of the study. DATA SYNTHESIS: In a pooled analysis of patients treated with antipsychotics, the relative risk (RR) of tardive dyskinesia in Black compared with White patients was 1.03 (95% CI 0.85, 1.24); the RR of extrapyramidal symptoms in East Asian compared with non-East Asian patients was 1.38 (95% CI 1.11, 1.72); the RR of hyperglycaemia in Black compared with non-Black patients was 1.55 (95% CI 0.95, 2.53); and the RR of diabetes mellitus in non-White compared with White patients was 1.35 (95% CI 0.95, 1.92). It was impossible to perform pooled analysis of data from studies investigating antidepressants due to insufficient data. CONCLUSIONS: We found limited evidence of ethnic differences in the risk of ADRs. The clinical implications of these results remain unclear because of confounding factors. Further progress will require improved recruitment of patients from different ethnic groups and an established consensus on how to define ethnicity.
Authors: J Steven Lamberti; G Oana Costea; David Olson; John F Crilly; Kumar Maharaj; Xin Tu; Adrienne Groman; Marci B Dietz; Margaret P Bushey; Telva Olivares; Karen Wiener Journal: J Clin Psychiatry Date: 2005-07 Impact factor: 4.384
Authors: C Morgan; R Mallett; G Hutchinson; H Bagalkote; K Morgan; P Fearon; P Dazzan; J Boydell; K McKenzie; G Harrison; R Murray; P Jones; T Craig; J Leff Journal: Br J Psychiatry Date: 2005-04 Impact factor: 9.319
Authors: D V Jeste; M P Caligiuri; J S Paulsen; R K Heaton; J P Lacro; M J Harris; A Bailey; R L Fell; L A McAdams Journal: Arch Gen Psychiatry Date: 1995-09
Authors: M H Chakos; J M Alvir; M G Woerner; A Koreen; S Geisler; D Mayerhoff; S Sobel; J M Kane; M Borenstein; J A Lieberman Journal: Arch Gen Psychiatry Date: 1996-04
Authors: Rebecca N Jerome; Jill M Pulley; Nila A Sathe; Shanthi Krishnaswami; Alyssa B Dickerson; Katherine J Worley; Consuelo H Wilkins Journal: Ethn Dis Date: 2020-04-02 Impact factor: 1.847
Authors: Sunita Sharma; Amy Murphy; Judie Howrylak; Blanca Himes; Michael H Cho; Jen-Hwa Chu; Gary M Hunninghake; Anne Fuhlbrigge; Barbara Klanderman; John Ziniti; Jody Senter-Sylvia; Andy Liu; Stanley J Szefler; Robert Strunk; Mario Castro; Nadia N Hansel; Gregory B Diette; Becky M Vonakis; N Franklin Adkinson; Vincent J Carey; Benjamin A Raby Journal: Genet Epidemiol Date: 2011-02 Impact factor: 2.135
Authors: Virginia L Stauffer; Jennifer L Sniadecki; Kevin W Piezer; Jennifer Gatz; Sara Kollack-Walker; Vicki Poole Hoffmann; Robert Conley; Todd Durell Journal: BMC Psychiatry Date: 2010-11-03 Impact factor: 3.630
Authors: Seetal Dodd; Gin S Malhi; John Tiller; Isaac Schweitzer; Ian Hickie; Jon Paul Khoo; Darryl L Bassett; Bill Lyndon; Philip B Mitchell; Gordon Parker; Paul B Fitzgerald; Marc Udina; Ajeet Singh; Steven Moylan; Francesco Giorlando; Carolyn Doughty; Christopher G Davey; Michael Theodoros; Michael Berk Journal: Aust N Z J Psychiatry Date: 2011-09 Impact factor: 5.744